Carsten Wessig
Research Subjects
Carsten Wessig has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Claudia Sommer
Department of Neurology, University Hospital Würzburg, Würzburg, Germany
2 shared publications Guido Stoll
2 shared publicationsMartin Bendszus
2 shared publications- Ansgar Schütz
Department of Neuroradiology, University of Wuerzburg, Josef-Schneider-Straße 11, Wuerzburg, 97080, Germany
1 shared publication - Camelia-Maria Monoranu
Department of Neuropathology, Institute of Pathology, University of Würzburg, Würzburg, Germany
1 shared publication - Christoph Kleinschnitz
Department of Neurology, University Hospital Essen, Essen, Germany
1 shared publication
Latest Publications
- 28 October 2013
- Published by Wiley in Muscle & Nerve
- Vol. 48 (6) , 983-988
Sporadic late onset nemaline myopathy and immunoglobulin deposition disease
Introduction: In monoclonal gammopathy, organ dysfunction can occur due to deposition of immunoglobulin fragments. A rare form of acquired myopathy often associated with monoclonal gammopathy is sporadic late onset nemaline myopathy (SLONM), which is characterized by nemaline rods in myofibers. The pathogenetic link between monoclonal gammopathy and SLONM has not yet been elucidated. Methods: Case report of a patient with monoclonal gammopathy who developed a progressive myopathy, finally diagnosed as SLONM. Results: A muscle biopsy showed mild myopathic changes. A second biopsy 1 year after clinical onset demonstrated deposition of immunoglobulin light and heavy chains and the presence of nemaline rods. The patient experienced marked improvement of muscle strength after autologous stem cell transplantation and treatment with bortezomib, a therapy that is known to be effective in light chain deposition disease. Conclusions: We speculate that deposition of light and heavy chains, rather than nemaline bodies, has myotoxic effects on skeletal muscle. Muscle Nerve 48: 983–988, 2013
- 28 October 2013
- Published by Wiley in Muscle & Nerve
- Vol. 48 (6) , 983-988
Sporadic late onset nemaline myopathy and immunoglobulin deposition disease
Introduction: In monoclonal gammopathy, organ dysfunction can occur due to deposition of immunoglobulin fragments. A rare form of acquired myopathy often associated with monoclonal gammopathy is sporadic late onset nemaline myopathy (SLONM), which is characterized by nemaline rods in myofibers. The pathogenetic link between monoclonal gammopathy and SLONM has not yet been elucidated. Methods: Case report of a patient with monoclonal gammopathy who developed a progressive myopathy, finally diagnosed as SLONM. Results: A muscle biopsy showed mild myopathic changes. A second biopsy 1 year after clinical onset demonstrated deposition of immunoglobulin light and heavy chains and the presence of nemaline rods. The patient experienced marked improvement of muscle strength after autologous stem cell transplantation and treatment with bortezomib, a therapy that is known to be effective in light chain deposition disease. Conclusions: We speculate that deposition of light and heavy chains, rather than nemaline bodies, has myotoxic effects on skeletal muscle. Muscle Nerve 48: 983–988, 2013
- Open Access
- 10 January 2013
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 7 (1) , 14
Fatal atypical reversible posterior leukoencephalopathy syndrome: a case report
Reversible posterior leukoencephalopathy syndrome – a reversible subacute global encephalopathy clinically presenting with headache, altered mental status, visual symptoms such as hemianopsia or cortical blindness, motor symptoms, and focal or generalized seizures – is characterized by a subcortical vasogenic edema symmetrically affecting posterior brain regions. Complete reversibility of both clinical signs and magnetic resonance imaging lesions is regarded as a defining feature of reversible posterior leukoencephalopathy syndrome. Reversible posterior leukoencephalopathy syndrome is almost exclusively seen in the setting of a predisposing clinical condition, such as pre-eclampsia, systemic infections, sepsis and shock, certain autoimmune diseases, various malignancies and cytotoxic chemotherapy, transplantation and concomitant immunosuppression (especially with calcineurin inhibitors) as well as episodes of abrupt hypertension. We describe for the first time clinical, radiological and histological findings in a case of reversible posterior leukoencephalopathy syndrome with an irreversible and fatal outcome occurring in the absence of any of the known predisposing clinical conditions except for a hypertensive episode.
- 10 January 2013
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 7 (1) , 14
Open AccessFatal atypical reversible posterior leukoencephalopathy syndrome: a case report
Reversible posterior leukoencephalopathy syndrome – a reversible subacute global encephalopathy clinically presenting with headache, altered mental status, visual symptoms such as hemianopsia or cortical blindness, motor symptoms, and focal or generalized seizures – is characterized by a subcortical vasogenic edema symmetrically affecting posterior brain regions. Complete reversibility of both clinical signs and magnetic resonance imaging lesions is regarded as a defining feature of reversible posterior leukoencephalopathy syndrome. Reversible posterior leukoencephalopathy syndrome is almost exclusively seen in the setting of a predisposing clinical condition, such as pre-eclampsia, systemic infections, sepsis and shock, certain autoimmune diseases, various malignancies and cytotoxic chemotherapy, transplantation and concomitant immunosuppression (especially with calcineurin inhibitors) as well as episodes of abrupt hypertension. We describe for the first time clinical, radiological and histological findings in a case of reversible posterior leukoencephalopathy syndrome with an irreversible and fatal outcome occurring in the absence of any of the known predisposing clinical conditions except for a hypertensive episode.
- 1 January 2012
- Published by Springer Nature
- p. 153-163
Die entzündlichen Myopathien – autoimmun bedingte Myositiden
- 1 January 2012
- Published by Springer Nature
- p. 153-163
Die entzündlichen Myopathien – autoimmun bedingte Myositiden
- 1 January 2012
- Published by Springer Nature
- p. 115-151
Immunneuropathien
- 1 March 2008
- Published by Elsevier in Experimental Neurology
- Vol. 210 (1) , 137-143
Gadofluorine M-enhanced magnetic resonance nerve imaging: Comparison between acute inflammatory and chronic degenerative demyelination in rats
- 1 March 2008
- Published by Elsevier in Experimental Neurology
- Vol. 210 (1) , 137-143
Gadofluorine M-enhanced magnetic resonance nerve imaging: Comparison between acute inflammatory and chronic degenerative demyelination in rats
- 1 March 2007
- Published by Elsevier in Experimental Neurology
- Vol. 204 (1) , 14-19
In vivo visualization of focal demyelination in peripheral nerves by gadofluorine M-enhanced magnetic resonance imaging
- 1 March 2007
- Published by Elsevier in Experimental Neurology
- Vol. 204 (1) , 14-19
In vivo visualization of focal demyelination in peripheral nerves by gadofluorine M-enhanced magnetic resonance imaging